Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjun Yu

Showing results (321-330 of 325) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 325 results.
Cancer Cell|September 10, 2024
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancerJiachen Xu, Rui Wan, Yiran Cai, et al.
Signal Transduction and Targeted Therapy|December 23, 2024
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trialJia Zhong, Kailun Fei, Lin Wu, et al.
Nature|March 31, 2012
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Nature|December 19, 2018
Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Cell|July 29, 2017
Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi ScreeningE Robert McDonald, Antoine de Weck, Michael R Schlabach, et al.
Pageof 33

Showing results (321-330 of 325) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 325 results.
Cancer Cell|September 10, 2024
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancerJiachen Xu, Rui Wan, Yiran Cai, et al.
Signal Transduction and Targeted Therapy|December 23, 2024
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trialJia Zhong, Kailun Fei, Lin Wu, et al.
Nature|March 31, 2012
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Nature|December 19, 2018
Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Cell|July 29, 2017
Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi ScreeningE Robert McDonald, Antoine de Weck, Michael R Schlabach, et al.
Pageof 33